Financials • Specialty Insurers
$63.72 ▲ +0.17
(+0.27%)
MKT CAP: $6.51B • VOL: 1.30M
52W L $56 52W H $80
FAF // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $7.45B | $6.13B | $6.00B |
| YoY Revenue Growth % | +21.6% | +2.1% | — |
| Gross Profit | $3.28B | $2.70B | $2.64B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $733.7M | $154.7M | $255.8M |
| Operating Margin % | 9.8% | 2.5% | 4.3% |
| Net Income (GAAP) | $621.8M | $131.1M | $216.8M |
| EBITDA (Normalized) | $1.00B | $375.3M | $471.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $950.8M | $897.5M | $354.3M |
| Capital Expenditures (CapEx) | $335.3M | $275.8M | $270.2M |
| Free Cash Flow (FCF) | $615.5M | $621.7M | $84.1M |
| FCF Margin % | 8.3% | 10.1% | 1.4% |
| Return on Invested Capital (ROIC %) | 6.5% | 1.6% | 4.6% |
| Cash & Short-Term Equivalents | $1.39B | $1.72B | $792.5M |
| Total Debt (Short + Long Term) | $4.82B | $4.49B | $1.69B |
| Total Stockholders' Equity | $5.50B | $4.91B | $3.46B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FAF.